secwatch.observer — SEC 8-K summary
======================================

Issuer:     Prestige Consumer Healthcare Inc. (PBH)
CIK:        0001295947
Form:       8-K
Filed at:   2026-02-05T23:59:59+00:00
Accession:  0001295947-26-000006
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Prestige Q3 revenue $283.4M, down 2.4% YoY; adjusted EPS $1.14 vs $1.22
-----------------------------------------------------------------------

- GAAP diluted EPS $0.97; adjusted diluted EPS $1.14 (down from $1.22); net income $46.7M.
- Narrowed FY2026 revenue outlook to ~$1.1B from $1.1-1.115B; adjusted EPS ~$4.54.
- Repurchased ~0.8M shares in Q3 for $45.8M; YTD repurchases ~2.3M shares at $155.6M.
- Closed acquisition of eye care supplier Pillar5 Pharma in December 2025.
- Clear Eyes supply constraints continue; management expects supply improvements in coming quarters.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1295947/000129594726000006/0001295947-26-000006-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1295947/000129594726000006/pbh-20260205.htm
  HTML page:      https://secwatch.observer/filing/0001295947-26-000006

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer